Literature DB >> 29036786

Pancreatic cancer and associated exosomes.

Chengfei Zhao1,2,1, Feng Gao3,1, Shaohuang Weng1, Qicai Liu4.   

Abstract

Pancreatic cancers with poor prognosis are highly malignant, readily metastatic and of immune tolerance, mainly due to delayed detection. The metastatic progression and immune tolerance of pancreatic cancer is greatly attributed to the intercellular communication. However, exosomes are deemed to be the most important tool of intercellular communicators. Thus, we present a review of pancreatic cancer and exosomes in this article. We intensively summarize the progress of early pancreatic cancer and the relationship of the proliferation, progression and metastasis of pancreatic cancer and pancreatic cancer-derived exosomes, and propose new ideas of the study of pancreatic cancer.

Entities:  

Keywords:  Pancreatic cancer; early detection; exosomes; immune tolerance; pancreatic intraepithelial neoplasia

Mesh:

Substances:

Year:  2017        PMID: 29036786     DOI: 10.3233/CBM-170258

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  10 in total

Review 1.  Molecular Profiling of Liquid Biopsies for Precision Oncology.

Authors:  Edgar E Gonzalez-Kozlova
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

2.  Identifying pancreatic cancer-associated miRNAs using weighted gene co-expression network analysis.

Authors:  Pengfei Lyu; Zhengwen Hao; Haoruo Zhang; Jun Li
Journal:  Oncol Lett       Date:  2022-07-05       Impact factor: 3.111

Review 3.  Effect of P2X purinergic receptors in tumor progression and as a potential target for anti-tumor therapy.

Authors:  Wen-Jun Zhang
Journal:  Purinergic Signal       Date:  2021-01-09       Impact factor: 3.765

Review 4.  Long non-coding RNAs in brain tumors: roles and potential as therapeutic targets.

Authors:  Sung-Hyun Kim; Key-Hwan Lim; Sumin Yang; Jae-Yeol Joo
Journal:  J Hematol Oncol       Date:  2021-05-12       Impact factor: 17.388

Review 5.  Tissue-derived extracellular vesicles in cancers and non-cancer diseases: Present and future.

Authors:  Su-Ran Li; Qi-Wen Man; Xin Gao; Hao Lin; Jing Wang; Fu-Chuan Su; Han-Qi Wang; Lin-Lin Bu; Bing Liu; Gang Chen
Journal:  J Extracell Vesicles       Date:  2021-12

Review 6.  The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives.

Authors:  Shun Wang; Yan Zheng; Feng Yang; Le Zhu; Xiao-Qiang Zhu; Zhe-Fang Wang; Xiao-Lin Wu; Cheng-Hui Zhou; Jia-Yan Yan; Bei-Yuan Hu; Bo Kong; De-Liang Fu; Christiane Bruns; Yue Zhao; Lun-Xiu Qin; Qiong-Zhu Dong
Journal:  Signal Transduct Target Ther       Date:  2021-07-05

Review 7.  The potential roles of exosomes in pancreatic cancer initiation and metastasis.

Authors:  Wei Sun; Ying Ren; Zaiming Lu; Xiangxuan Zhao
Journal:  Mol Cancer       Date:  2020-09-02       Impact factor: 27.401

Review 8.  Extracellular Vesicles: New Endogenous Shuttles for miRNAs in Cancer Diagnosis and Therapy?

Authors:  Stefano Martellucci; Nicola Salvatore Orefice; Adriano Angelucci; Amalia Luce; Michele Caraglia; Silvia Zappavigna
Journal:  Int J Mol Sci       Date:  2020-09-04       Impact factor: 5.923

Review 9.  Exosomes as Pleiotropic Players in Pancreatic Cancer.

Authors:  Laura De Lellis; Rosalba Florio; Maria Cristina Di Bella; Davide Brocco; Francesca Guidotti; Nicola Tinari; Antonino Grassadonia; Rossano Lattanzio; Alessandro Cama; Serena Veschi
Journal:  Biomedicines       Date:  2021-03-09

10.  The effects of CYP24A1 on clinicopathological features and the prognosis of pancreatic ductal adenocarcinoma.

Authors:  Wei Gao; Teng-Fei Wang; Wen Yi; Wei-Min Tong
Journal:  Transl Cancer Res       Date:  2020-08       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.